
Chairwoman Maloney's Opening Statement: Unsustainable Drug Prices (Part III)

Oversight Committee
66 followers
9 Video Views·May 18, 2021
Committee on Oversight and Reform Chairwoman Carolyn B. Maloney’s opening statement, as prepared for delivery, during today’s full committee hearing examining the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.
